% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

  • terridiamond158 terridiamond158 Mar 19, 2014 2:54 PM Flag

    Why Did SNTA Cancel European Breast Conference,,

    their not on schedule

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Funny. They are on the agenda for 9:45am Tomorrow (see below - copied directly from the EBCC-9 Programme):

      THU 08:45 - 10:15

      Proffered Paper : Tomorrow's Practice Changing Abstracts

      Chair: F. Penault-Llorca (France)

      Tailoring local therapy in post-menopausal endocrine responsive HER2neu negative breast cancer patients based on their genetic risk profile using Endopredict
      Speaker: F. Fitzal (Austria)

      Display abstract

      Genomic profiling of breast cancer during pregnancy
      Speaker: H. Azim jr (Belgium)

      Display abstract

      The Princess Margaret Cancer Centre experience with molecular profiling of metastatic breast cancer to screen for genotype-matched clinical trials
      Speaker: W. Chen (Canada)

      Display abstract

      A randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally-advanced hormone-receptor-positive breast cancer: Preliminary results
      Speaker: N. Quenel Tueux (France)

      Display abstract

      Targeting HSP90 in breast cancer: ENCHANT-1 (NCT01677455) phase 2 proof of concept study of ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer (TNBC)
      Speaker: D. Cameron (United Kingdom)

      Display abstract

      Discussant: A. Thompson (United Kingdom)

      Sentiment: Strong Buy

    • liar, for those of you interested see my previous posts about ebcc9

      Sentiment: Strong Buy

0.2948+0.0346(+13.30%)Jul 1 4:00 PMEDT